AACR
14 kwietnia 2018
AACR Annual Meeting 2018, 14-18 April 2018, Chicago, IL, USA
Rok
2018
Cel
RVU120 (CDK8/CDK19), A2A/A2B, SHMT
Zasoby na tej stronie
Pobierz zasoby
- plik pdf
"Characterization of novel dual A2A/A2B adenosine receptor antagonists for cancer immunotherapy"
Pobierz - plik pdf
"CDK8 inhibitor SEL120-34A targets CD34 positive AML cells by regulation of transcriptional programs involved in the maintenance of leukemia stem cells"
Pobierz - plik pdf
"Discovery of novel SHMT small molecule inhibitors for cancer treatment"
Pobierz